Process Industries · Agricultural Commodities/Milling · NSE: NATHBIOGEN · data 2026-10-09
Nath Bio-Genes (India) Ltd.
Health check: Average (5.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹137.79
Market cap
₹257 cr
P/E
6.8
P/B
—
ROE
6.3%
ROCE
7.3%
Debt / equity
0.2
Dividend yield
1.48%
1-year return
-19.5%
52-week high
₹204
52-week low
₹126.15
Operating margin
9.3%
Growth
| Revenue (last 12 months) | ₹490 cr |
| Net profit (last 12 months) | ₹39 cr |
| Sales growth, 3 years (yearly) | 15.2% |
| Profit growth, 3 years (yearly) | 5.9% |
Similar companies
Axita Cotton Ltd. (AXITA) · Peria Karamalai Tea & Produce Co. Ltd. (PKTEA) · KCP Sugar & Industries Corp. Ltd. (KCPSUGIND) · K.M. Sugar Mills Ltd. (KMSUGAR) · Jay Shree Tea & Industries Ltd. (JAYSREETEA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open NATHBIOGEN in NSE Scanner →